Apoptotic response to TGF-β in fetal hepatocytes depends upon their state of differentiation

被引:39
作者
Sánchez, A
Alvarez, AM
Pedrosa, JML
Roncero, C
Benito, M
Fabregat, I [1 ]
机构
[1] UCM, CSIC, Ctr Mixto, Dept Bioquim & Biol Mol 2, Madrid 28040, Spain
[2] Univ Complutense Madrid, Fac Farm, Ctr Citometria Flujo & Microscopia Confocal, Fac Farm, E-28040 Madrid, Spain
[3] Abbott Labs, Dept I&D, Granada 18004, Spain
关键词
hepatocyte; TGF-beta; apoptosis; differentiation; hepatocarcinogenesis;
D O I
10.1006/excr.1999.4624
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Transforming growth factor-beta (TGF-beta 1) induces death of fetal hepatocytes by an apoptotic mechanism. However, even when very high concentrations and/or long-term exposure to the cytokine is used, 40-50% of cells always survive. The process of cell survival is coincident with changes in morphology and phenotype, with cells showing a fibroblastic appearance and eliciting an epithelial-fibroblastic transition. Surviving cells continue responding to TGF-beta in terms of growth control. Expression of liver-specific genes is very low in these cells; this effect is due to the decrease in their rate of transcription as soon as 2 h after the addition of the factor. Surviving cells present a decreased DNA binding activity for liver-enriched transcription factors, an increased DNA binding activity for AP-1, and a high expression of protooncogenes. These cells are immature hepatocytes since in the presence of the appropriate signal (i.e., epidermal growth factor), they can differentiate, organizing in cell clusters and increasing both liver-specific mRNA expression and liver-enriched transcription factor activity. In accord with these results, TGF-beta, secreted at high concentrations during liver carcinogenesis, might induce death of normal cells while providing a selective advantage for the survival of cells that are "partially transformed" or "less differentiated" and unresponsive to the factor. (C) 1999 Academic Press.
引用
收藏
页码:281 / 291
页数:11
相关论文
共 45 条
[1]   ALTERED METABOLIC AND ADHESIVE PROPERTIES AND INCREASED TUMORIGENESIS ASSOCIATED WITH INCREASED EXPRESSION OF TRANSFORMING GROWTH FACTOR-BETA-1 [J].
ARRICK, BA ;
LOPEZ, AR ;
ELFMAN, F ;
EBNER, R ;
DAMSKY, CH ;
DERYNCK, R .
JOURNAL OF CELL BIOLOGY, 1992, 118 (03) :715-726
[2]  
Arsura M, 1997, CELL GROWTH DIFFER, V8, P1049
[3]   THE CELL BIOLOGY OF TRANSFORMING GROWTH-FACTOR-BETA [J].
BARNARD, JA ;
LYONS, RM ;
MOSES, HL .
BIOCHIMICA ET BIOPHYSICA ACTA, 1990, 1032 (01) :79-87
[4]   MOLECULAR ASPECTS OF MESENCHYMAL-EPITHELIAL INTERACTIONS [J].
BIRCHMEIER, C ;
BIRCHMEIER, W .
ANNUAL REVIEW OF CELL BIOLOGY, 1993, 9 :511-540
[5]  
BIRCHMEIER W, 1995, EPITHELIAL MESENCHYM
[6]  
Brown TL, 1998, CELL GROWTH DIFFER, V9, P869
[7]  
CAULIN C, 1995, CELL GROWTH DIFFER, V6, P1027
[8]  
CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2
[9]   TGF beta 1 inhibits the formation of benign skin tumors, but enhances progression to invasive spindle carcinomas in transgenic mice [J].
Cui, W ;
Fowlis, DJ ;
Bryson, S ;
Duffie, E ;
Ireland, H ;
Balmain, A ;
Akhurst, RJ .
CELL, 1996, 86 (04) :531-542
[10]   DIFFERENTIAL PROLIFERATIVE RESPONSE OF CULTURED FETAL AND REGENERATING HEPATOCYTES TO GROWTH-FACTORS AND HORMONES [J].
DEJUAN, C ;
BENITO, M ;
ALVAREZ, A ;
FABREGAT, I .
EXPERIMENTAL CELL RESEARCH, 1992, 202 (02) :495-500